SHERI SHAW: Open Payments
NPI 1972142164 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 19 payments from 6 companies in 2025. Trend: 2023 $2,382 · 2024 $2,978 · 2025 $2,077
Food & beverage: $1,952Education: $124
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $741 |
| Neurocrine BioSciences, Inc. | 6 | $575 |
| ABBVIE INC. | 3 | $260 |
| Alkermes, Inc. | 2 | $247 |
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| Axsome Therapeutics, Inc. | 1 | $119 |
Products named: INGREZZA, UZEDY, AUSTEDO XR, COBENFY, VRAYLAR, VIVITROL, LYBALVI, Auvelity.
Industry payments across TX — which companies pay providers there.
